Expertise
Myocardial Infarction
Venous Thrombosis
Drug-Eluting Stents
Stents
Odds Ratio
Therapeutics
Confidence Intervals
Thrombosis
Organizations
Publications
Recent
Paolo Zocca, M. D., Kok, M. M., van der Heijden, L. C., van Houwelingen, K. G., Hartmann, M., de Man, F. H. A. F., ... von Birgelen, C. (2018). High bleeding risk patients with acute coronary syndromes treated with contemporary drug-eluting stents and Clopidogrel or Ticagrelor: Insights from CHANGE DAPT . International journal of cardiology. DOI: 10.1016/j.ijcard.2018.03.116
Kandhai-Ragunath, J. J., Doggen, C. J. M., van der Heijden, L. C., Kok, M. M., Zocca, P., de Wagenaar, B., ... von Birgelen, C. (2018). Serial assessment of endothelial function 1, 6, and 12 months after ST-elevation myocardial infarction. Heart and vessels, 1-8. DOI: 10.1007/s00380-018-1145-1
Busger op Vollenbroek, F. T. M., Doggen, C. J. M., Janssens, R. W. A., & Bernelot Moens, H. J. (2018). Dermatological guidelines for monitoring methotrexate treatment reduce drug-survival compared to rheumatological guidelines. PLoS ONE, 13(3), [e0194401]. DOI: 10.1371/journal.pone.0194401
von Birgelen, C., Kok, M. M., Sattar, N., Zocca, P., Doelman, C., Kant, G. D., ... Tandjung, K. (2018). “Silent” Diabetes and Clinical Outcome After Treatment With Contemporary Drug-Eluting Stents: The BIO-RESORT Silent Diabetes Study. JACC : cardiovascular interventions, 11(5), 448-459. DOI: 10.1016/j.jcin.2017.10.038
Zocca, P., Kok, M. M., Tandjung, K., Danse, P. W., Jessurun, G. A. J., Hautvast, R. W. M., ... von Birgelen, C. (2018). 5-Year Outcome Following Randomized Treatment of All-Comers With Zotarolimus-Eluting Resolute Integrity and Everolimus-Eluting PROMUS Element Coronary Stents: Final Report of the DUTCH PEERS (TWENTE II) Trial. JACC : cardiovascular interventions, 11(5), 500-502. DOI: 10.1016/j.jcin.2017.11.031
van der Heijden, L. C., Kok, M. M., Zocca, P., Jessurun, G. A. J., Schotborgh, C. E., Roguin, A., ... von Birgelen, C. (2018). Bioresorbable Polymer-Coated Orsiro Versus Durable Polymer-Coated Resolute Onyx Stents (BIONYX): Rationale and design of the randomized TWENTE IV multicenter trial. American heart journal, 198, 25-32. DOI: 10.1016/j.ahj.2017.12.011
van der Heijden, L. C., Kok, M. M., Zocca, P., Sen, H., Löwik, M. M., Mariani, S., ... von Birgelen, C. (2018). Long-term outcome of consecutive patients with previous coronary bypass surgery, treated with newer-generation drug-eluting stents. Journal of the American Heart Association, 7(3), [e007212]. DOI: 10.1161/JAHA.117.007212
Van Der Heijden, L. C., Kok, M. M., Löwik, M. M., Danse, P. W., Jessurun, G. A. J., Hautvast, R. W. M., ... Von Birgelen, C. (2017). Three-year safety and efficacy of treating all-comers with newer-generation Resolute Integrity or PROMUS Element stents in the randomised Dutch PEERS (TWENTE II) trial. EuroIntervention, 12(17), 2128-2131. DOI: 10.4244/EIJ-D-16-00571
Kandhai-Ragunath, J. J., de Wagenaar, B., Doelman, C., van Es, J., Jørstad, H. T., Peters, R. J. G., ... von Birgelen, C. (2017). Endothelial function after ST-elevation myocardial infarction in patients with high levels of high-sensitivity CRP and Lp-PLA2: A substudy of the RESPONSE randomized trial. Cardiovascular Revascularization Medicine, 18(3), 202-206. DOI: 10.1016/j.carrev.2016.12.019
Attard, R., Dingli, P., Doggen, C. J. M., Cassar, K., Farrugia, R., & Wettinger, S. B. (2017). The impact of passive and active smoking on inflammation, lipid profile and the risk of myocardial infarction. Open Heart, 4(2), 1-9. [e000620]. DOI: 10.1136/openhrt-2017-000620
UT Research Information System
Courses
Contact Details
Visiting Address
University of Twente
Faculty of Behavioural, Management and Social Sciences
Ravelijn
(building no. 10), room 5252
Hallenweg 17
7522NH Enschede
The Netherlands
Mailing Address
University of Twente
Faculty of Behavioural, Management and Social Sciences
Ravelijn
5252
P.O. Box 217
7500 AE Enschede
The Netherlands